Patel Prashant
CIK 1617460 · View on SEC EDGAR ↗
First SEC filing: March 21, 2025 · Latest: March 21, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 22, 2026 | MEDS | X | 100,000 | — | — | 0 Direct | — | Acquired | (price as of 2026-08-19) |
| June 22, 2026 | MEDS | X | 100,000 | — | — | 282,365 Direct | +54.84% | Acquired | (price as of 2026-08-19) |
| March 31, 2026 | MEDS | A | 5,000,000 | — | — | 5,000,000 Direct | — | Acquired | (price as of 2026-08-19) |
| March 31, 2026 | MEDS | A | 5,000,000 | $0.20 | $1,000,000 | 9,118,247 Direct | +121.41% | Acquired | -85.9% (price as of 2026-08-19) |
| May 13, 2019 | SCNX | A | 100,000 | — | — | 12,250,000 Direct | +0.82% | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | MEDS | Warrant | Common Stock (100,000) | $0.00 | March 31, 2031 | 100,000 | Acquired |
| March 31, 2026 | MEDS | Warrant | Common Stock (5,000,000) | $0.00 | March 31, 2031 | 5,000,000 | Acquired |
| May 13, 2019 | SCNX | Stock Option | Common Stock (100,000) | $0.44 | May 13, 2019 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 2,236,000 | Direct |
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 4,472,000 | Indirect |
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 2,400,000 | Indirect |
| Aug. 20, 2014 | SCNX | Common Stock | 7,350,000 | Direct |
| Aug. 20, 2014 | SCNX | Common Stock | 2,500,000 | Indirect |
| Aug. 20, 2014 | SCNX | Common Stock | 2,400,000 | Indirect |